Elias Sayour

3.4k total citations · 1 hit paper
81 papers, 2.0k citations indexed

About

Elias Sayour is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Elias Sayour has authored 81 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Immunology, 44 papers in Oncology and 29 papers in Molecular Biology. Recurrent topics in Elias Sayour's work include Immunotherapy and Immune Responses (42 papers), CAR-T cell therapy research (29 papers) and RNA Interference and Gene Delivery (21 papers). Elias Sayour is often cited by papers focused on Immunotherapy and Immune Responses (42 papers), CAR-T cell therapy research (29 papers) and RNA Interference and Gene Delivery (21 papers). Elias Sayour collaborates with scholars based in United States, China and Germany. Elias Sayour's co-authors include Duane A. Mitchell, Adam Grippin, Maryam Rahman, Jianping Huang, John H. Sampson, Gabriel De Leon, Aida Karachi, Héctor R. Méndez‐Gómez, Kyle Dyson and Roger E. McLendon and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Elias Sayour

72 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer mRNA vaccines: clinical advances and future opportunities

2024 94 citations Elias Sayour, Duane A. Mitchell et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elias Sayour United States	25	1000	962	657	531	408	81	2.0k
Syed R. Husain United States	30	772 0.8×	1.2k 1.2×	688 1.0×	437 0.8×	231 0.6×	54	2.5k
Jana Portnow United States	18	1.2k 1.2×	432 0.4×	800 1.2×	713 1.3×	538 1.3×	60	2.2k
John Choi United States	18	468 0.5×	488 0.5×	575 0.9×	489 0.9×	220 0.5×	42	1.5k
Denis Migliorini Switzerland	21	708 0.7×	715 0.7×	543 0.8×	224 0.4×	241 0.6×	72	1.6k
Robert J. Schmittling United States	18	1.4k 1.4×	1.3k 1.4×	570 0.9×	1.0k 1.9×	264 0.6×	31	2.5k
Dongrui Wang United States	17	1.4k 1.4×	688 0.7×	688 1.0×	160 0.3×	480 1.2×	39	1.9k
Jill Schartner United States	19	538 0.5×	1.2k 1.3×	586 0.9×	497 0.9×	140 0.3×	27	2.1k
Kendra L. Congdon United States	14	614 0.6×	718 0.7×	999 1.5×	417 0.8×	106 0.3×	25	1.9k
Smita K. Nair United States	14	619 0.6×	601 0.6×	513 0.8×	292 0.5×	105 0.3×	39	1.4k
Ling-Yuan Kong United States	25	1.5k 1.5×	1.5k 1.6×	1.1k 1.6×	991 1.9×	175 0.4×	30	3.2k

Countries citing papers authored by Elias Sayour

Since Specialization

Citations

This map shows the geographic impact of Elias Sayour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elias Sayour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elias Sayour more than expected).

Fields of papers citing papers by Elias Sayour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elias Sayour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elias Sayour. The network helps show where Elias Sayour may publish in the future.

Co-authorship network of co-authors of Elias Sayour

This figure shows the co-authorship network connecting the top 25 collaborators of Elias Sayour. A scholar is included among the top collaborators of Elias Sayour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elias Sayour. Elias Sayour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Grippin, Adam, N. Li, Christian Braun, et al.. (2025). LBA54 SARS-CoV-2 mRNA vaccines sensitize tumors to immune checkpoint blockade. Annals of Oncology. 36. S1598–S1598.

Grippin, Adam, Nan Li, Ryan Sun, et al.. (2025). 419 SARS-CoV-2 mRNA vaccines sensitize immunologically ‘cold’ tumors to immune checkpoint blockade. Regular and Young Investigator Award Abstracts. A475–A475.

Doonan, Bently P., Shawna C. Willey, Ji‐Hyun Lee, et al.. (2024). Novel RNA-nanoparticle vaccine for the treatment of early melanoma recurrence following adjuvant anti-PD-1 antibody therapy.. Journal of Clinical Oncology. 42(16_suppl). TPS9609–TPS9609. 2 indexed citations

Thomas, Nagheme, Sandra C. Yan, Aida Karachi, et al.. (2024). Development of a murine laser interstitial thermotherapy system. Neurosurgical FOCUS. 57(5). E10–E10.

Grippin, Adam, Erin L. Young, Ellen T. Chang, et al.. (2024). 995MO Association of SARS-COV-2 mRNA vaccines with tumor PD-L1 expression and clinical responses to immune checkpoint blockade. Annals of Oncology. 35. S677–S678. 2 indexed citations

Wright, Karen, Cassie Kline, Mohamed S Abdelbaki, et al.. (2024). Phase IB study of tovorafenib for children with relapsed/recurrent low-grade gliomas and other MAPK pathway activated tumors.. Journal of Clinical Oncology. 42(16_suppl). 10001–10001. 1 indexed citations

Ogando‐Rivas, Elizabeth, John A. Ligon, Linchun Jin, et al.. (2023). Bioconjugated liquid-like solid enhances characterization of solid tumor - chimeric antigen receptor T cell interactions. Acta Biomaterialia. 172. 466–479. 9 indexed citations

Doonan, Bently P., Shawna C. Willey, Ji‐Hyun Lee, et al.. (2023). 772 Novel RNA-nanoparticle vaccine for the treatment of early melanoma recurrence following adjuvant anti-PD-1 antibody therapy. SHILAP Revista de lepidopterología. A867–A869. 2 indexed citations

Hwang, Eugene, Elias Sayour, Catherine Flores, et al.. (2022). The current landscape of immunotherapy for pediatric brain tumors. Nature Cancer. 3(1). 11–24. 34 indexed citations

10.

Wright, Karen, Cassie Kline, Mohamed S Abdelbaki, et al.. (2022). CTNI-53. PNOC014: PHASE IB STUDY RESULTS OF DAY101(TOVORAFENIB) FOR CHILDREN WITH LOW-GRADE GLIOMAS (LGGS) AND OTHER RAS/RAF/MEK/ERK PATHWAY-ACTIVATED TUMORS. Neuro-Oncology. 24(Supplement_7). vii84–vii84. 9 indexed citations

11.

Karachi, Aida, Farhad Dastmalchi, Jianping Huang, et al.. (2021). Optimizing T Cell-Based Therapy for Glioblastoma. Frontiers in Immunology. 12. 705580–705580. 13 indexed citations

12.

Sujjitjoon, Jatuporn, Elias Sayour, Mongkol Uiprasertkul, et al.. (2020). GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma – assessing tumor and T cell interaction. Translational Oncology. 14(2). 100971–100971. 26 indexed citations

13.

Chulanetra, Monrat, Elias Sayour, Lamis Eldjerou, et al.. (2020). GD2 chimeric antigen receptor modified T cells in synergy with sub-toxic level of doxorubicin targeting osteosarcomas.. PubMed. 10(2). 674–687. 41 indexed citations

14.

Long, Yu, Haipeng Tao, Aida Karachi, et al.. (2019). Dysregulation of Glutamate Transport Enhances Treg Function That Promotes VEGF Blockade Resistance in Glioblastoma. Cancer Research. 80(3). 499–509. 93 indexed citations

15.

Dastmalchi, Farhad, Aida Karachi, Changlin Yang, et al.. (2019). Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling. Journal for ImmunoTherapy of Cancer. 7(1). 321–321. 30 indexed citations

16.

Saraswathula, Anirudh, Elizabeth A. Reap, Bryan D. Choi, et al.. (2016). Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy. Cancer Immunology Immunotherapy. 65(2). 205–211. 6 indexed citations

17.

Pham, Christina, Catherine Flores, Changlin Yang, et al.. (2015). Differential Immune Microenvironments and Response to Immune Checkpoint Blockade among Molecular Subtypes of Murine Medulloblastoma. Clinical Cancer Research. 22(3). 582–595. 87 indexed citations

18.

Chulanetra, Monrat, Elias Sayour, Lamis Eldjerou, et al.. (2015). Abstract 3157: Novel GD2-specific chimeric antigen receptor-modified T cells targeting osteosarcoma. Cancer Research. 75(15_Supplement). 3157–3157. 1 indexed citations

19.

Flores, Catherine, Christina Pham, David J. Snyder, et al.. (2015). Novel role of hematopoietic stem cells in immunologic rejection of malignant gliomas. OncoImmunology. 4(3). e994374–e994374. 41 indexed citations

20.

Sánchez-Pérez, Luis, Bryan D. Choi, Elizabeth A. Reap, et al.. (2013). BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide. Cancer Immunology Immunotherapy. 62(6). 983–987. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact